Skip to content

The application of goal-directed fluid therapy in elderly patients undergoing minimally invasive esophagectomy

The application of goal-directed fluid therapy in elderly patients undergoing minimally invasive esophagectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013352
Enrollment
Unknown
Registered
2017-11-12
Start date
2017-11-20
Completion date
Unknown
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal carcinoma

Interventions

GDFT group:GDFT
normal group:traditional fluid therapy

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. ASA I-III; 2. Aged =65 years; 3. Newly diagnosed esophageal carcinoma, will undergo minimal invasive esophagectomy.;Inclusion criteria: 1. ASA I-III; 2. Aged =65 years; 3. Newly diagnosed esophageal carcinoma, will undergo minimal invasive esophagectomy.

Exclusion criteria

Exclusion criteria: 1. Patients with major cardiovascular diseases at the baseline; 2. End-stage renal diseases requiring dialysis; 3. Major infection (including but not limited to septicemia); 4. coagulopathy; 5. using immunosuppressive drugs; 6. having a history of anesthetics allergy; 7. can not receive femoral artery puncture ;Exclusion criteria: 1. Patients with major cardiovascular diseases at the baseline; 2. End-stage renal diseases requiring dialysis; 3. Major infection (including but not limited to septicemia); 4. coagulopathy; 5. using immunosuppressive drugs; 6. having a history of anesthetics allergy; 7. can not receive femoral artery puncture

Design outcomes

Primary

MeasureTime frame
short term mortality after surgery;the incidence of postoperative complication;Other major adverse events prior to patient discharge from hospital, including postoperative hypoxemia, electrolyte disturbances, deep vein thrombosis/pulmonary embolism;ICU and hospital stay;perioperative bleeding volume and urine volume;;short term mortality after surgery;the incidence of postoperative complication;Other major adverse events prior to patient discharge from hospital, including postoperative hypoxemia, electrolyte disturbances, deep vein thrombosis/pulmonary embolism;ICU and hospital stay;perioperative bleeding volume and urine volume;

Countries

China

Contacts

Public ContactWei Tang;Wei Tang ;

Shanghai Chest Hospital;Shanghai Chest Hospital

tangwei0114@126.com;tangwei0114@126.com+86 13917878083;+86 13917878083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026